Frontlight ResearchEarly access
Trial site
Shree Hospital & Critical Care Centre
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- COPD1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Celldex Therapeutics2 trials
- Upstream Bio Inc.1 trial
Running trials
Enrolling by invitation
Active, not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic spontaneous urticaria1 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026